NDC 0069-0238-01
Ruxience 100 mg/10mL
rituximab-pvvr · INJECTION, SOLUTION
Ruxience is a injection, solution containing rituximab-pvvr at a strength of 100 mg/10mL. Manufactured by Pfizer Laboratories Div Pfizer Inc.
Key Facts
- Brand Name
- Ruxience
- Generic Name
- rituximab-pvvr
- NDC Code (Package)
0069-0238-01- NDC Code (Product)
0069-0238- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Strength
- 100 mg/10mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761103
- Drug Class
- CD20-directed Cytolytic Antibody [EPC]
- Marketing Start
- 01/23/2020
Recall History
No Recall HistoryView Full Drug Page
Ruxience — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.